Shah Capital intends to vote against Novavax's board nominees, executive compensation [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
and ?the executive compensation package at Novavax's upcoming annual meeting, renewing ?pressure for changes at the vaccine maker. In a letter to the company on Wednesday, ?hedge fund founder Himanshu Shah said management has failed to implement aggressive cost-cutting measures and urged leadership to reduce costs and opportunistically buy back 10–20 million shares. Shah Capital, which owns 9% of Novavax and is its second-largest ?shareholder, has been pushing the ?biotech's board to pursue strategic changes, including a potential sale. The firm wants a like-minded strategic long-term investor to ?take a 10–20% ownership stake to reshape the company. In the letter, shared exclusively with Reuters, the investment firm said the partnership with Sanofi has not ?benefited Novavax. "We ?are both surprised and frustrated" by ?Sanofi's continued delay in launching ?late-stage results for the COVID/influenza combo vaccine, a market worth more than $5 billion, Shah said. CALLS FOR
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- 3 Reasons NVAX is Risky and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Is Novavax (NVAX) A Potential Opportunity After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- 2 Growth Stocks Set to Flourishand 1 We Question [Yahoo! Finance]Yahoo! Finance
- New Novavax R&D Leader Raises Questions On Valuation Gap And Outlook [Yahoo! Finance]Yahoo! Finance
- 3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/26/26 - Beat
NVAX
Sec Filings
- 4/8/26 - Form SCHEDULE
- 3/27/26 - Form SCHEDULE
- 3/12/26 - Form 4
- NVAX's page on the SEC website